244 related articles for article (PubMed ID: 20629473)
1. The value of value of information: best informing research design and prioritization using current methods.
Eckermann S; Karnon J; Willan AR
Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
[TBL] [Abstract][Full Text] [Related]
2. Use of value of information in UK health technology assessments.
Mohiuddin S; Fenwick E; Payne K
Int J Technol Assess Health Care; 2014 Dec; 30(6):553-70. PubMed ID: 25816821
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.
Koffijberg H; Knies S; Janssen MP
Value Health; 2018 Feb; 21(2):203-209. PubMed ID: 29477402
[TBL] [Abstract][Full Text] [Related]
4. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E
Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
[TBL] [Abstract][Full Text] [Related]
6. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
7. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
Basu A; Meltzer D
Med Decis Making; 2018 May; 38(4):427-438. PubMed ID: 29529923
[TBL] [Abstract][Full Text] [Related]
8. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
[TBL] [Abstract][Full Text] [Related]
9. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.
Tappenden P; Chilcott JB; Eggington S; Oakley J; McCabe C
Health Technol Assess; 2004 Jun; 8(27):iii, 1-78. PubMed ID: 15215017
[TBL] [Abstract][Full Text] [Related]
10. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.
Kim DD; Guzauskas GF; Bennette CS; Basu A; Veenstra DL; Ramsey SD; Carlson JJ
Pharmacoeconomics; 2020 Feb; 38(2):171-179. PubMed ID: 31631254
[TBL] [Abstract][Full Text] [Related]
11. Adjusting Estimates of the Expected Value of Information for Implementation: Theoretical Framework and Practical Application.
Andronis L; Barton PM
Med Decis Making; 2016 Apr; 36(3):296-307. PubMed ID: 26566775
[TBL] [Abstract][Full Text] [Related]
12. Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies.
Eckermann S; Willan AR
Pharmacoeconomics; 2011 Jul; 29(7):563-77. PubMed ID: 21671686
[TBL] [Abstract][Full Text] [Related]
13. Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators.
Heath A; Baio G; Manolopoulou I; Welton NJ
Pharmacoeconomics; 2024 May; 42(5):479-486. PubMed ID: 38583100
[TBL] [Abstract][Full Text] [Related]
14. Expected value of information and decision making in HTA.
Eckermann S; Willan AR
Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
[TBL] [Abstract][Full Text] [Related]
15. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
Hoomans T; Fenwick EA; Palmer S; Claxton K
Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
[TBL] [Abstract][Full Text] [Related]
16. Globally optimal trial design for local decision making.
Eckermann S; Willan AR
Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
[TBL] [Abstract][Full Text] [Related]
17. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation.
Grimm SE; Pouwels X; Ramaekers BLT; van Ravesteyn NT; Sankatsing VDV; Grutters J; Joore MA
Value Health; 2021 Aug; 24(8):1126-1136. PubMed ID: 34372978
[TBL] [Abstract][Full Text] [Related]
18. A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research.
Andronis L; Billingham LJ; Bryan S; James ND; Barton PM
Med Decis Making; 2016 Apr; 36(3):321-34. PubMed ID: 26209474
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
